COURT-RULING ·Filed Sep 9, 2026

MRK

Merck & Co., Inc.
NEUTRAL
Impact 1/10
Horizonimmediate Processed21d 16h ago CourtView Ruling on CourtListener
Court ruling (district)
Actionable Insight • Neutral

This filing is a routine procedural order with no trading implications for MRK. Monitor the case for future substantive rulings on motions to dismiss, summary judgment, or trial.

DirectionNeutral
Confidencehigh
Horizonimmediate
Latest settled — T+5d
MRK ▼ -1.78% at T+5d
NEUTRAL call ✗ call lost -1.78% · α vs SPY -1.12% · entry $147.53 → $144.91
Next anchor: T+20d in 4d
Latest observation: T+13 +1.62% FF3 residual α
Entry anchored
Sep 8, 05:39 PM ET
via 1-min bar
T+1d
-1.91%
call -1.91% · α -1.31%
$144.71
settled 23d ago
T+5d
-1.78%
call -1.78% · α -1.12%
$144.91
settled 17d ago
T+20d
—
call — · α —
—
in 4d
T+60d
—
call — · α —
—
in 2mo

Price Chart

Loading chart...

Executive Summary

This is a routine procedural order granting an attorney's application for pro hac vice admission in a case where Merck & Co., Inc. is a defendant. The order does not address any substantive legal issues, liability, damages, or injunctive relief. It has no financial or operational impact on Merck.

Court Ruling Details

Ruling Date
Sep 9, 2026
Court
United States District Court for the Northern District of California
Court Level
District
Judge
William S. H. Orrick
Case Type
other
Ruling Type
procedural
Will It Be Appealed?
N/A (final)
Precedent Risk
LOW

Key Facts

  • The court granted an application for an out-of-state attorney to appear pro hac vice in the case Kaiser Foundation Health Plan Inc v. Merck & Company Inc. et al.
  • This is a purely administrative procedural order with no substantive ruling on the merits of the case.
  • No damages, injunctions, or financial exposure were addressed in this filing.

Financial Impact

No financial impact — the order is procedural only.

Risk Factors

  • No new risks identified from this filing.

Market Snapshot

Price
$144.62
Volume
199
Exchange
NYSE
Sector
Pharmaceutical Preparations
Analyst Consensus
72% bullish (36 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 court opinion from CourtListener.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-a8a3257445-MRK
20 reports for MRK
Performance horizon
100% Hit rate 4 of 4 directional calls best @ T+20▲ +18.67%Aug 6, 2026
Filters
Rows
Reports for MRK — sortable, filterable
TypeNow
Sep 11, 2026
21d ago
Court Ruling
NEUTRAL ★ 1/10
$143.93 $146.87▲ +2.04%▲ +2.26%$143.81 (−0.08%)
Sep 9, 2026
23d ago
Court Ruling
NEUTRAL ★ 1/10
$147.53 $144.91▼ −1.78%▼ −1.12%$143.81 (−2.52%)
Aug 27, 2026
5w ago
Court Ruling
NEUTRAL ★ 1/10
$149.54 $152.34▲ +1.87%▲ +1.60%$143.81 (−3.83%)
Aug 24, 2026
5w ago
Court Ruling
BEARISH ★ 5/10
$150.66 $147.73▲ +1.95%▲ +2.42%$143.81 (+4.55%)
Aug 20, 2026
6w ago
ANALYST-UPGRADE
MIXED ★ 5/10
$148.99 $149.54▲ +0.37%▼ −0.75%$143.81 (−3.48%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.84 $152.55▲ +12.30%▲ +13.67%$143.81 (+5.87%)
Aug 13, 2026
7w ago
Court Ruling
NEUTRAL ★ 3/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 13, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$135.55 $148.99▲ +9.92%▲ +11.88%$143.81 (+6.09%)
Aug 12, 2026
7w ago
ANALYST-UPGRADE
BULLISH ★ 4/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Aug 12, 2026
7w ago
Insider Cluster
NEUTRAL ★ 2/10
$132.92 $152.20▲ +14.51%▲ +14.95%$143.81 (+8.19%)
Showing 10 of 20

US Market Status

Market Open — Closes in 6h 27m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more — parsed and scored by AI.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access